EFFECT OF CHLOROQUINE AND PRIMAQUINE ON ANTIPYRINE METABOLISM

被引：48
作者：
BACK, DJ
PURBA, HS
PARK, BK
WARD, SA
ORME, ML
机构：
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 16卷 / 05期
关键词：
D O I：
10.1111/j.1365-2125.1983.tb02206.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：497 / 502
页数：6
相关论文
共 22 条
[1]   INHIBITION OF DRUG-METABOLISM BY THE ANTI-MALARIAL DRUGS CHLOROQUINE AND PRIMAQUINE IN THE RAT [J].
BACK, DJ ;
PURBA, HS ;
STAIGER, C ;
ORME, ML ;
BRECKENRIDGE, AM .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (02) :257-263
[2]   INHIBITION OF ANTIPYRINE METABOLISM BY BETA-ADRENOCEPTOR ANTAGONISTS [J].
BAX, NDS ;
LENNARD, MS ;
TUCKER, GT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :779-784
[3]  
BENOWITZ NL, 1977, CLIN PHARMACOL THER, V22, P259
[4]   COMPARISON OF THE INVIVO AND INVITRO RATES OF FORMATION OF THE 3 MAIN OXIDATIVE METABOLITES OF ANTIPYRINE IN MAN [J].
BOOBIS, AR ;
BRODIE, MJ ;
KAHN, GC ;
TOVERUD, EL ;
BLAIR, IA ;
MURRAY, S ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :771-777
[5]   DIFFERENTIAL-EFFECTS OF ENZYME-INDUCTION ON ANTIPYRINE METABOLITE FORMATION [J].
DANHOF, M ;
VERBEEK, RMA ;
VANBOXTEL, CJ ;
BOEIJINGA, JK ;
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (03) :379-386
[6]   ASSAY OF ANTIPYRINE AND ITS PRIMARY METABOLITES IN PLASMA, SALIVA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND SOME PRELIMINARY-RESULTS IN MAN [J].
DANHOF, M ;
GROOTVANDERVIS, ED ;
BREIMER, DD .
PHARMACOLOGY, 1979, 18 (04) :210-223
[7]   STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN .1. ORAL-ADMINISTRATION OF 250, 500 AND 1000 MG TO HEALTHY-VOLUNTEERS [J].
DANHOF, M ;
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) :529-537
[8]  
HOMEIDA M, 1978, CLIN PHARMACOL THER, V24, P228
[9]   EFFECT OF SPIRONOLACTONE ON ANTIPYRINE METABOLISM IN MAN [J].
HUFFMAN, DH ;
SHOEMAN, DW ;
PENTIKAINEN, P ;
AZARNOFF, DL .
PHARMACOLOGY, 1973, 10 (06) :338-344
[10]   ASSESSMENT OF THE DRUG-METABOLISM CAPACITY OF THE LIVER [J].
PARK, BK .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (05) :631-651
123